| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK2 DOCK3 TANK RASGRF1 ESR1 ADGRB3 PSMD2 RABGAP1 DENND4C HEXIM1 GSTP1 MALT1 THBS1 PPP2R2C STX4 RABEP1 PPP1R2C ARHGAP29 SESN2 PLCG1 MCF2L PLCE1 SPINK5 | 2.27e-04 | 1418 | 145 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | tubulin binding | PDE4B CENPF KIF1B RABGAP1 KIF3A CEP350 SETD2 NDC80 CCT5 YWHAQ KIF13A | 2.98e-04 | 428 | 145 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK2 DOCK3 RASGRF1 ADGRB3 RABGAP1 DENND4C RABEP1 ARHGAP29 SESN2 PLCG1 MCF2L PLCE1 | 3.36e-04 | 507 | 145 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK2 DOCK3 RASGRF1 ADGRB3 RABGAP1 DENND4C RABEP1 ARHGAP29 SESN2 PLCG1 MCF2L PLCE1 | 3.36e-04 | 507 | 145 | 12 | GO:0030695 |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 7.05e-07 | 73 | 142 | 7 | GO:0051784 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 2.68e-06 | 217 | 142 | 10 | GO:0000075 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 3.06e-06 | 172 | 142 | 9 | GO:0051783 | |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 4.16e-06 | 134 | 142 | 8 | GO:0007088 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 5.17e-06 | 64 | 142 | 6 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 5.17e-06 | 64 | 142 | 6 | GO:0010965 | |
| GeneOntologyBiologicalProcess | plus-end-directed vesicle transport along microtubule | 6.29e-06 | 6 | 142 | 3 | GO:0072383 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 6.77e-06 | 67 | 142 | 6 | GO:0051306 | |
| GeneOntologyBiologicalProcess | plus-end-directed organelle transport along microtubule | 1.10e-05 | 7 | 142 | 3 | GO:0072386 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 1.75e-05 | 163 | 142 | 8 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 1.76e-05 | 79 | 142 | 6 | GO:1905818 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 2.62e-05 | 51 | 142 | 5 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 2.62e-05 | 51 | 142 | 5 | GO:0071173 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 3.17e-05 | 53 | 142 | 5 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 3.17e-05 | 53 | 142 | 5 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 3.17e-05 | 53 | 142 | 5 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 3.17e-05 | 53 | 142 | 5 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 3.17e-05 | 53 | 142 | 5 | GO:0071174 | |
| GeneOntologyBiologicalProcess | chromosome separation | 3.26e-05 | 88 | 142 | 6 | GO:0051304 | |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 3.80e-05 | 55 | 142 | 5 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 3.80e-05 | 55 | 142 | 5 | GO:1905819 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | CENPF TRIAP1 ESR1 INTS3 TTK ZFY PSMG2 NDC80 EIF2AK4 YWHAQ NEK11 | 4.29e-05 | 362 | 142 | 11 | GO:0010948 |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 4.52e-05 | 57 | 142 | 5 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 4.52e-05 | 57 | 142 | 5 | GO:0051985 | |
| GeneOntologyBiologicalProcess | cell cycle process | ANKRD31 CENPF TRIAP1 ESR1 RTTN NEK7 MCM2 INTS3 ITGB1 TTK KIF3A ZFY SETD2 PSMG2 NDC80 NUP37 EIF2AK4 YWHAQ IL1A KIF13A NIPBL NEK11 CDC23 EXOC4 | 4.69e-05 | 1441 | 142 | 24 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 5.03e-05 | 95 | 142 | 6 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 5.80e-05 | 60 | 142 | 5 | GO:0033047 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 5.99e-05 | 98 | 142 | 6 | GO:1902099 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 6.04e-05 | 311 | 142 | 10 | GO:1901988 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 6.71e-05 | 100 | 142 | 6 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 7.92e-05 | 103 | 142 | 6 | GO:0044784 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | CENPF TRIAP1 ESR1 INTS3 TTK HEXIM1 ZFY PSMG2 NDC80 EIF2AK4 YWHAQ NEK11 | 9.05e-05 | 464 | 142 | 12 | GO:0045786 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 9.68e-05 | 266 | 142 | 9 | GO:0033044 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 9.78e-05 | 107 | 142 | 6 | GO:2001251 | |
| GeneOntologyBiologicalProcess | organelle localization | CENPF KIF1B SPG11 FYCO1 ITGB1 YWHAZ KIF3A AP1AR STX4 AKAP9 NDC80 YWHAQ KIF13A CDC23 EXOC4 | 1.04e-04 | 703 | 142 | 15 | GO:0051640 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | CENPF KIF1B SPG11 FYCO1 ITGB1 YWHAZ KIF3A AP1AR NDC80 YWHAQ KIF13A CDC23 EXOC4 | 1.05e-04 | 546 | 142 | 13 | GO:0051656 |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.20e-04 | 111 | 142 | 6 | GO:0033045 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF1B RTTN NEK7 SPG11 FYCO1 ITGB1 TTK KIF3A CEP350 SETD2 AKAP9 NDC80 VANGL1 DNAH17 DYNLL2 YWHAQ KIF13A TUBD1 CFAP46 | 1.21e-04 | 1058 | 142 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ANKRD31 CCPG1 CENPF JADE3 TRIAP1 ESR1 NEK7 INTS3 ITGB1 TTK HEXIM1 ZFY SETD2 PSMG2 NDC80 EIF2AK4 YWHAQ IL1A KIF13A NEK11 CDC23 | 1.40e-04 | 1256 | 142 | 21 | GO:0051726 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.50e-04 | 282 | 142 | 9 | GO:0045930 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 1.76e-04 | 119 | 142 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CENPF TRIAP1 ESR1 NEK7 MCM2 INTS3 ITGB1 TTK SETD2 PSMG2 NDC80 YWHAQ IL1A TUBD1 NIPBL NEK11 CDC23 EXOC4 | 2.13e-04 | 1014 | 142 | 18 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ANKRD31 CENPF TRIAP1 ESR1 INTS3 TTK ZFY SETD2 PSMG2 NDC80 EIF2AK4 YWHAQ IL1A KIF13A NEK11 CDC23 | 2.39e-04 | 845 | 142 | 16 | GO:0010564 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CENPF TRIAP1 ESR1 MCM2 INTS3 ITGB1 TTK SETD2 PSMG2 NDC80 YWHAQ IL1A NIPBL NEK11 CDC23 EXOC4 | 2.69e-04 | 854 | 142 | 16 | GO:1903047 |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 2.80e-04 | 4 | 142 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CENPF TRIAP1 ESR1 NEK7 MCM2 FYCO1 RABGAP1 TTK COTL1 ZFY AP1AR PSMG2 AKAP9 NDC80 CCT5 FZD5 TLR2 KIRREL1 YWHAQ IL1A CDC23 | 3.45e-04 | 1342 | 142 | 21 | GO:0033043 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 3.49e-04 | 316 | 142 | 9 | GO:0140014 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 4.06e-04 | 139 | 142 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | vesicle transport along microtubule | 4.19e-04 | 51 | 142 | 4 | GO:0047496 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 5.82e-04 | 24 | 142 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 6.58e-04 | 25 | 142 | 3 | GO:2001224 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 6.76e-04 | 212 | 142 | 7 | GO:0000070 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 6.85e-04 | 421 | 142 | 10 | GO:0010639 | |
| GeneOntologyBiologicalProcess | negative regulation of translation in response to stress | 6.93e-04 | 6 | 142 | 2 | GO:0032055 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 7.76e-04 | 217 | 142 | 7 | GO:1903034 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 8.19e-04 | 219 | 142 | 7 | GO:1901991 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | CENPF TRIAP1 ESR1 NEK7 INTS3 TTK PSMG2 NDC80 YWHAQ IL1A NEK11 CDC23 | 8.47e-04 | 594 | 142 | 12 | GO:0007346 |
| GeneOntologyBiologicalProcess | nuclear division | ANKRD31 CENPF ESR1 TTK ZFY PSMG2 NDC80 YWHAQ IL1A NIPBL CDC23 | 8.49e-04 | 512 | 142 | 11 | GO:0000280 |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 8.81e-04 | 62 | 142 | 4 | GO:2001222 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | CENPF TRIAP1 INTS3 TTK ZFY PSMG2 NDC80 EIF2AK4 YWHAQ NEK11 CDC23 | 9.05e-04 | 516 | 142 | 11 | GO:1901987 |
| GeneOntologyBiologicalProcess | plasminogen activation | 9.23e-04 | 28 | 142 | 3 | GO:0031639 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 9.34e-04 | 224 | 142 | 7 | GO:0051650 | |
| GeneOntologyCellularComponent | centrosome | PDE4B CENPF RTTN NEK7 CCDC81 RABGAP1 TEX9 CCDC141 KIF3A CEP350 RABL6 AKAP9 NDC80 CCT5 DYNLL2 YWHAQ KIF13A EXOC4 | 7.34e-06 | 770 | 146 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | PDE4B CENPF RTTN NEK7 CCDC81 RABGAP1 TEX9 CCDC141 KIF3A CEP350 RABL6 AKAP9 NDC80 CCT5 DYNLL2 YWHAQ KIF13A TUBD1 EXOC4 | 2.26e-05 | 919 | 146 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.40e-04 | 161 | 146 | 7 | GO:0005875 | |
| Domain | Kinesin-like | 8.64e-06 | 6 | 143 | 3 | IPR022164 | |
| Domain | DUF3694 | 8.64e-06 | 6 | 143 | 3 | PF12473 | |
| Domain | ARM-like | 4.46e-05 | 270 | 143 | 10 | IPR011989 | |
| Domain | DUF1088 | 5.82e-05 | 2 | 143 | 2 | IPR010508 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 5.82e-05 | 2 | 143 | 2 | IPR003272 | |
| Domain | DUF1088 | 5.82e-05 | 2 | 143 | 2 | PF06469 | |
| Domain | ARM-type_fold | DOCK2 DOCK3 CAND2 RTTN PSMD2 NBEA LTN1 LRBA AP4B1 HEATR5B NIPBL | 6.14e-05 | 339 | 143 | 11 | IPR016024 |
| Domain | K_chnl_inward-rec_Kir_N | 1.74e-04 | 3 | 143 | 2 | IPR013673 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 1.74e-04 | 3 | 143 | 2 | IPR006794 | |
| Domain | IRK_N | 1.74e-04 | 3 | 143 | 2 | PF08466 | |
| Domain | Zfx_Zfy_act | 1.74e-04 | 3 | 143 | 2 | PF04704 | |
| Domain | EF-hand_like | 1.87e-04 | 15 | 143 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.87e-04 | 15 | 143 | 3 | PF00387 | |
| Domain | PLCYc | 1.87e-04 | 15 | 143 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.87e-04 | 15 | 143 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.87e-04 | 15 | 143 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 1.87e-04 | 15 | 143 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.87e-04 | 15 | 143 | 3 | IPR015359 | |
| Domain | PI-PLC-X | 3.30e-04 | 18 | 143 | 3 | PF00388 | |
| Domain | PLCXc | 3.30e-04 | 18 | 143 | 3 | SM00148 | |
| Domain | Kinesin-like_KIF1-typ | 3.46e-04 | 4 | 143 | 2 | IPR022140 | |
| Domain | KIF1B | 3.46e-04 | 4 | 143 | 2 | PF12423 | |
| Domain | PIPLC_X_DOMAIN | 3.89e-04 | 19 | 143 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.89e-04 | 19 | 143 | 3 | IPR000909 | |
| Domain | DOCK_N | 5.73e-04 | 5 | 143 | 2 | PF16172 | |
| Domain | DOCK_N | 5.73e-04 | 5 | 143 | 2 | IPR032376 | |
| Domain | DUF4704 | 5.73e-04 | 5 | 143 | 2 | IPR031570 | |
| Domain | DUF4704 | 5.73e-04 | 5 | 143 | 2 | PF15787 | |
| Domain | Kinesin_assoc | 8.56e-04 | 6 | 143 | 2 | PF16183 | |
| Domain | PH_BEACH | 8.56e-04 | 6 | 143 | 2 | PF14844 | |
| Domain | Kinesin_assoc | 8.56e-04 | 6 | 143 | 2 | IPR032405 | |
| Domain | - | 8.93e-04 | 25 | 143 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 8.93e-04 | 25 | 143 | 3 | IPR017946 | |
| Domain | 14_3_3 | 1.19e-03 | 7 | 143 | 2 | SM00101 | |
| Domain | 1433_1 | 1.19e-03 | 7 | 143 | 2 | PS00796 | |
| Domain | 1433_2 | 1.19e-03 | 7 | 143 | 2 | PS00797 | |
| Domain | 14-3-3_domain | 1.19e-03 | 7 | 143 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 1.19e-03 | 7 | 143 | 2 | IPR023409 | |
| Domain | 14-3-3 | 1.19e-03 | 7 | 143 | 2 | PF00244 | |
| Domain | 14-3-3 | 1.58e-03 | 8 | 143 | 2 | IPR000308 | |
| Domain | PH-BEACH_dom | 1.58e-03 | 8 | 143 | 2 | IPR023362 | |
| Domain | EPL1 | 1.58e-03 | 8 | 143 | 2 | PF10513 | |
| Domain | - | 1.58e-03 | 8 | 143 | 2 | 2.30.29.40 | |
| Domain | Enhancer_polycomb-like_N | 1.58e-03 | 8 | 143 | 2 | IPR019542 | |
| Domain | PH_BEACH | 1.58e-03 | 8 | 143 | 2 | PS51783 | |
| Domain | - | 1.63e-03 | 222 | 143 | 7 | 1.25.10.10 | |
| Domain | BEACH | 2.02e-03 | 9 | 143 | 2 | PS50197 | |
| Domain | Beach | 2.02e-03 | 9 | 143 | 2 | PF02138 | |
| Domain | - | 2.02e-03 | 9 | 143 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.02e-03 | 9 | 143 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.02e-03 | 9 | 143 | 2 | IPR000409 | |
| Domain | TPR-like_helical_dom | 2.14e-03 | 233 | 143 | 7 | IPR011990 | |
| Domain | Prefoldin | 2.27e-03 | 72 | 143 | 4 | IPR009053 | |
| Domain | DHR-1_domain | 3.06e-03 | 11 | 143 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.06e-03 | 11 | 143 | 2 | PS51651 | |
| Domain | DHR_1 | 3.06e-03 | 11 | 143 | 2 | PS51650 | |
| Domain | DHR-2 | 3.06e-03 | 11 | 143 | 2 | PF06920 | |
| Domain | DOCK | 3.06e-03 | 11 | 143 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.06e-03 | 11 | 143 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.06e-03 | 11 | 143 | 2 | PF14429 | |
| Domain | DHR-2 | 3.06e-03 | 11 | 143 | 2 | IPR027357 | |
| Domain | Kinesin_motor_CS | 3.79e-03 | 41 | 143 | 3 | IPR019821 | |
| Domain | MIRO-like | 4.30e-03 | 13 | 143 | 2 | IPR013684 | |
| Domain | Roc | 4.30e-03 | 13 | 143 | 2 | PF08477 | |
| Domain | SH3_2 | 4.31e-03 | 86 | 143 | 4 | PF07653 | |
| Domain | SH3_2 | 4.31e-03 | 86 | 143 | 4 | IPR011511 | |
| Domain | Kinesin-like_fam | 4.34e-03 | 43 | 143 | 3 | IPR027640 | |
| Domain | - | 4.63e-03 | 44 | 143 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.63e-03 | 44 | 143 | 3 | PF00225 | |
| Domain | KISc | 4.63e-03 | 44 | 143 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.63e-03 | 44 | 143 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.63e-03 | 44 | 143 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.63e-03 | 44 | 143 | 3 | PS50067 | |
| Domain | - | 5.25e-03 | 207 | 143 | 6 | 1.25.40.10 | |
| Domain | PH_dom-like | 5.58e-03 | 426 | 143 | 9 | IPR011993 | |
| Domain | IRK | 6.51e-03 | 16 | 143 | 2 | PF01007 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 6.51e-03 | 16 | 143 | 2 | IPR013518 | |
| Domain | - | 6.51e-03 | 16 | 143 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 6.51e-03 | 16 | 143 | 2 | IPR016449 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.82e-05 | 74 | 105 | 6 | M41814 | |
| Pubmed | PDE4B CENPF NBEA RABGAP1 YWHAZ KIF3A NCOR2 AKAP9 YWHAQ EXOC4 | 1.08e-09 | 151 | 148 | 10 | 17043677 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZCCHC8 KIF1B ZNF507 RABGAP1 TTK ST13 KANSL3 NCOR2 SETD2 ARNT NDC80 RABEP1 DYNLL2 HELZ CDC23 EXOC4 | 5.09e-09 | 588 | 148 | 16 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | JADE3 ZCCHC8 KIF1B ZNF507 MCM2 INTS3 ZFX EIF3CL KANSL3 NCOR2 SETD2 TMPO HELZ PLCB3 CTPS1 SRSF9 NIPBL CDC23 | 6.12e-09 | 774 | 148 | 18 | 15302935 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CACNA1A ADGRB3 YWHAZ ZFX KIF3A ZFY RABL6 NCOR2 THBS1 CCT5 PLCB3 YWHAQ SPATS2 MCF2L | 1.81e-08 | 475 | 148 | 14 | 31040226 |
| Pubmed | DOCK3 ZCCHC8 KRT83 KIF1B ADGRB3 PSMD2 NBEA ZNF214 SHTN1 YWHAZ ST13 KIF3A CEP350 ZNF7 THBS1 PSMG2 RABEP1 PLCG1 LRBA ST18 NIPBL EXOC4 | 2.91e-08 | 1285 | 148 | 22 | 35914814 | |
| Pubmed | ZNF609 CAND2 JADE3 ZNF507 ADGRB3 MCM2 SPG11 LRRK1 KANSL3 CCT5 EIF2AK4 IGSF1 YWHAQ MED23 | 6.85e-08 | 529 | 148 | 14 | 14621295 | |
| Pubmed | 7.55e-08 | 3 | 148 | 3 | 30254632 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ZNF609 KRT15 MCM2 PSMD2 COTL1 YWHAZ EIF3CL GSTP1 NCOR2 CCT5 TMPO YWHAQ CTPS1 KLK2 SRSF9 | 1.80e-07 | 665 | 148 | 15 | 30457570 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CAND2 ZCCHC8 KIF1B PSMD2 INTS3 ITGB1 YWHAZ CEP350 PPP2R2C CCT5 VANGL1 YWHAQ CTPS1 HEATR5B | 1.81e-07 | 573 | 148 | 14 | 28330616 |
| Pubmed | ZNF609 CENPF ZCCHC8 ZNF507 RABGAP1 SHTN1 DENND4C NCOR2 RABEP1 LRBA CDC23 EXOC4 | 2.60e-07 | 418 | 148 | 12 | 34709266 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 21705626 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CENPF TRIAP1 ZCCHC8 THUMPD1 PSMD2 RABGAP1 ITGB1 TTK YWHAZ ST13 AKAP9 NDC80 CCT5 VANGL1 NUP37 TMPO YWHAQ SPATS2 SRSF9 MMUT CDC23 EXOC4 | 3.98e-07 | 1496 | 148 | 22 | 32877691 |
| Pubmed | KIF1B PSMD2 SHTN1 ITGB1 TTK DENND4C RABL6 CCT5 VANGL1 ARHGAP29 TMPO BOD1L1 LRBA CTPS1 EXOC4 | 3.98e-07 | 708 | 148 | 15 | 39231216 | |
| Pubmed | NBEA ITGB1 TTK YWHAZ RABL6 AP1AR CCT5 VANGL1 RABEP1 TMPO YWHAQ LRBA | 5.55e-07 | 449 | 148 | 12 | 31732153 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ZCCHC8 KIF1B SHTN1 TTK YWHAZ DENND4C CEP350 AKAP9 RABEP1 ANKRD11 HELZ BOD1L1 YWHAQ BRD1 KIF13A EXOC4 | 9.06e-07 | 861 | 148 | 16 | 36931259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KRT7 KIF1B THUMPD1 MCM2 PSMD2 RABGAP1 SHTN1 YWHAZ ST13 HEXIM1 EIF3CL RABL6 CCT5 NUP37 RABEP1 PLCB3 PLCG1 YWHAQ LRBA CTPS1 KIF13A | 1.02e-06 | 1455 | 148 | 21 | 22863883 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK2 EPPK1 PSMD2 INTS3 TTK NCOR2 NDC80 CCT5 NUP37 TMPO NIPBL CDC23 EXOC4 | 1.38e-06 | 582 | 148 | 13 | 20467437 |
| Pubmed | C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. | 1.50e-06 | 6 | 148 | 3 | 9543386 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPF NBEA SPG11 RABL6 CCT5 ANKRD11 FGB TMPO EIF2AK4 LRBA CTPS1 CDC23 | 1.60e-06 | 497 | 148 | 12 | 36774506 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 CENPF MCM2 PSMD2 ITGB1 YWHAZ CEP350 GSTP1 STX4 CCT5 VANGL1 TMPO YWHAQ HEATR5B SRSF9 NIPBL CDC23 | 1.88e-06 | 1024 | 148 | 17 | 24711643 |
| Pubmed | RABGAP1 ITGB1 COTL1 DENND4C RABL6 RABEP1 TMPO KIRREL1 LRBA EXOC4 | 2.10e-06 | 339 | 148 | 10 | 37232246 | |
| Pubmed | ZNF609 PSMD2 NBEA PPEF2 ITGB1 YWHAZ CEP350 NCOR2 AKAP9 CCT5 VANGL1 LTN1 TMPO HELZ KIRREL1 EIF2AK4 YWHAQ | 2.60e-06 | 1049 | 148 | 17 | 27880917 | |
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 2.61e-06 | 7 | 148 | 3 | 36096339 | |
| Pubmed | 3.66e-06 | 282 | 148 | 9 | 23667531 | ||
| Pubmed | CACNA1A PDE4B CENPF ADGRB3 NBEA FYCO1 SHTN1 YWHAZ KIF3A NCOR2 AKAP9 RABEP1 YWHAQ SPATS2 TNR NIPBL | 3.81e-06 | 963 | 148 | 16 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TANK JADE3 KIF1B ZNF507 TEX9 TTK CEP350 NDC80 CCT5 DYNLL2 ARHGAP29 YWHAQ AP4B1 FHIP1A EXOC4 | 3.95e-06 | 853 | 148 | 15 | 28718761 |
| Pubmed | 4.16e-06 | 8 | 148 | 3 | 7613034 | ||
| Pubmed | SHTN1 SETD2 CCT5 RABEP1 TMPO BOD1L1 YWHAQ LRBA CTPS1 MED23 CDC23 EXOC4 | 4.44e-06 | 549 | 148 | 12 | 38280479 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT7 EPPK1 PRAMEF10 CAND2 KRT15 FYCO1 YWHAZ THBS1 RABEP1 LTN1 YWHAQ EXOC4 | 5.82e-06 | 564 | 148 | 12 | 21565611 |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 7589147 | ||
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 10501179 | ||
| Pubmed | TDRD15 KIF1B NBEA TEX9 ITGB1 CEP350 RABL6 GSTP1 CCT5 VANGL1 TMPO KIRREL1 LRBA FAM219A | 6.41e-06 | 777 | 148 | 14 | 35844135 | |
| Pubmed | 6.44e-06 | 162 | 148 | 7 | 25796446 | ||
| Pubmed | THUMPD1 MCM2 RABGAP1 COTL1 HEXIM1 KANSL3 GSTP1 NCOR2 SETD2 PSMG2 CCT5 BOD1L1 MED23 SRSF9 NIPBL CDC23 | 7.28e-06 | 1014 | 148 | 16 | 32416067 | |
| Pubmed | CAND2 KIF1B CCDC141 ITGB1 YWHAZ ST13 KIF3A GSTP1 AKAP9 RABEP1 PLCE1 | 1.00e-05 | 497 | 148 | 11 | 23414517 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.04e-05 | 321 | 148 | 9 | 32098917 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 CENPF JADE3 ZCCHC8 SLFN5 SRBD1 INTS3 ZFX KANSL3 NCOR2 SETD2 ARNT HOXC10 ANKRD11 TMPO SRSF9 NIPBL CDC23 | 1.06e-05 | 1294 | 148 | 18 | 30804502 |
| Pubmed | DOCK2 PSMD2 FYCO1 ITGB1 TTK CEP350 NCOR2 CLCN3 NDC80 DYNLL2 TMPO HELZ YWHAQ LRBA CTPS1 HEATR5B EXOC4 | 1.06e-05 | 1168 | 148 | 17 | 19946888 | |
| Pubmed | NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses. | 1.22e-05 | 11 | 148 | 3 | 31114588 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.31e-05 | 120 | 148 | 6 | 31413325 | |
| Pubmed | 1.45e-05 | 72 | 148 | 5 | 34882091 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.50e-05 | 256 | 148 | 8 | 33397691 | |
| Pubmed | 1.58e-05 | 186 | 148 | 7 | 20673868 | ||
| Pubmed | 1.58e-05 | 186 | 148 | 7 | 20452482 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 30515972 | ||
| Pubmed | DOCK2 TDRD15 EPPK1 MCM2 PSMD2 COTL1 YWHAZ EIF3CL S100A3 GSTP1 CCT5 DYNLL2 YWHAQ CTPS1 | 1.62e-05 | 844 | 148 | 14 | 25963833 | |
| Pubmed | ZNF609 TANK SPG11 TEX9 ITGB1 DENND4C CEP350 SETD2 VANGL1 HELZ KIRREL1 BOD1L1 CTPS1 | 1.64e-05 | 733 | 148 | 13 | 34672954 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23785280 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9840812 | ||
| Pubmed | Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. | 1.80e-05 | 2 | 148 | 2 | 18765807 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35122963 | ||
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 1.80e-05 | 2 | 148 | 2 | 1691708 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8188262 | ||
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 1.80e-05 | 2 | 148 | 2 | 2497060 | |
| Pubmed | Estradiol activates chloride channels via estrogen receptor-α in the cell membranes of osteoblasts. | 1.80e-05 | 2 | 148 | 2 | 28468943 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8318216 | ||
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 1.80e-05 | 2 | 148 | 2 | 38602753 | |
| Pubmed | Nipbl Interacts with Zfp609 and the Integrator Complex to Regulate Cortical Neuron Migration. | 1.80e-05 | 2 | 148 | 2 | 28041881 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12716983 | ||
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 1.80e-05 | 2 | 148 | 2 | 8487630 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32668300 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 35093119 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 2265557 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 37224961 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16314422 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24971610 | ||
| Pubmed | Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. | 1.80e-05 | 2 | 148 | 2 | 19329779 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32219319 | ||
| Pubmed | [Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen]. | 1.80e-05 | 2 | 148 | 2 | 18546531 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21946067 | ||
| Pubmed | Chemokine receptor CXCR4-beta1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells. | 1.80e-05 | 2 | 148 | 2 | 15746965 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 9171229 | ||
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 1.80e-05 | 2 | 148 | 2 | 2041734 | |
| Pubmed | Differential expression of molecular motors in the motor cortex of sporadic ALS. | 1.80e-05 | 2 | 148 | 2 | 17418584 | |
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 1.80e-05 | 2 | 148 | 2 | 9126493 | |
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 1.80e-05 | 2 | 148 | 2 | 15705530 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18658130 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23723373 | ||
| Pubmed | Zfx mutation results in small animal size and reduced germ cell number in male and female mice. | 1.80e-05 | 2 | 148 | 2 | 9187153 | |
| Pubmed | [Association of GSTP1 and PLCE1 gene polymorphisms with primary esophageal cancer]. | 1.80e-05 | 2 | 148 | 2 | 36317220 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31545499 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17591692 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17507648 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 2105457 | ||
| Pubmed | Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs. | 1.80e-05 | 2 | 148 | 2 | 1970799 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 2308929 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28251288 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28419445 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38403459 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15713534 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34324278 | ||
| Pubmed | 1.82e-05 | 263 | 148 | 8 | 34702444 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 KIF1B RABGAP1 SHTN1 INTS3 ITGB1 KANSL3 MALT1 NCOR2 PPP2R2C RABEP1 ANKRD11 BOD1L1 EIF2AK4 PLCG1 LRBA SPATS2 MCF2L EXOC4 | 1.97e-05 | 1489 | 148 | 19 | 28611215 |
| Pubmed | 1.98e-05 | 129 | 148 | 6 | 23022380 | ||
| Pubmed | 2.09e-05 | 13 | 148 | 3 | 21930703 | ||
| Pubmed | JADE3 SRBD1 SHTN1 DENND4C KIF3A CEP350 NDC80 DYNLL2 LRBA BRD1 MED23 EXOC4 | 2.21e-05 | 645 | 148 | 12 | 25281560 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KRT7 EPPK1 MCM2 CCDC80 ITGB1 YWHAZ CCT5 LTN1 LRBA CTPS1 SRSF9 EXOC4 | 2.27e-05 | 647 | 148 | 12 | 26618866 |
| Pubmed | ZNF609 SAMD9 INTS3 HEXIM1 ARNT CLCN3 HELZ PLCB3 EIF2AK4 AP4B1 EXOC4 PLCE1 | 2.38e-05 | 650 | 148 | 12 | 38777146 | |
| Pubmed | ZNF609 WWC3 KIF1B PSMD2 ITGB1 YWHAZ HEXIM1 KIF3A GSTP1 NCOR2 ARNT AKAP9 CCT5 TMPO YWHAQ SPATS2 SRSF9 | 2.45e-05 | 1247 | 148 | 17 | 27684187 | |
| Pubmed | 2.61e-05 | 201 | 148 | 7 | 25192599 | ||
| Interaction | RAB4A interactions | KIF1B NBEA RABGAP1 ITGB1 COTL1 DENND4C HEXIM1 RABL6 AP1AR STX4 VANGL1 RABEP1 TMPO KIRREL1 LRBA KIF13A EXOC4 | 3.37e-08 | 457 | 145 | 17 | int:RAB4A |
| Interaction | KDM1A interactions | KRT7 ZNF609 KRT15 CENPF ZCCHC8 ESR1 ZNF507 MCM2 FYCO1 RABGAP1 TEX9 SHTN1 DENND4C CEP350 MALT1 NCOR2 AKAP9 RABEP1 DYNLL2 ARHGAP29 LRBA MED23 CDC23 EXOC4 | 6.31e-08 | 941 | 145 | 24 | int:KDM1A |
| Interaction | DISC1 interactions | PDE4B RABGAP1 TEX9 CCDC141 YWHAZ HEXIM1 KIF3A CEP350 THBS1 AKAP9 PLCG1 YWHAQ AP4B1 BRD1 CDC23 EXOC4 | 8.47e-08 | 429 | 145 | 16 | int:DISC1 |
| Interaction | CCDC68 interactions | 4.29e-07 | 22 | 145 | 5 | int:CCDC68 | |
| Interaction | KRT8 interactions | KRT7 EPPK1 KRT15 ESR1 PPEF2 YWHAZ F11 HEXIM1 CEP350 AKAP9 NDC80 RABEP1 LTN1 HELZ YWHAQ | 7.08e-07 | 441 | 145 | 15 | int:KRT8 |
| Interaction | ATG16L1 interactions | DOCK2 TANK WWC3 ZCCHC8 PSMD2 RABGAP1 TEX9 TTK YWHAZ DENND4C HEXIM1 KIF3A CEP350 RABL6 AP1AR NDC80 CCT5 VANGL1 RABEP1 TLR2 KIRREL1 YWHAQ FHIP1A PDZD4 EXOC4 | 7.89e-07 | 1161 | 145 | 25 | int:ATG16L1 |
| Interaction | TGM2 interactions | MCM2 PSMD2 ITGB1 YWHAZ DENND4C GSTP1 THBS1 ARNT EIF2AK4 YWHAQ LRBA | 1.10e-06 | 235 | 145 | 11 | int:TGM2 |
| Interaction | ADORA3 interactions | 2.43e-06 | 14 | 145 | 4 | int:ADORA3 | |
| Interaction | PCM1 interactions | KRT15 KRT83 ESR1 KIF1B TEX9 TTK YWHAZ CEP350 AKAP9 NDC80 YWHAQ SPATS2 BRD1 EXOC4 | 3.14e-06 | 434 | 145 | 14 | int:PCM1 |
| Interaction | CEP85L interactions | 3.63e-06 | 33 | 145 | 5 | int:CEP85L | |
| Interaction | PFN1 interactions | ESR1 MCM2 NBEA RABGAP1 SHTN1 DENND4C HEXIM1 CEP350 AKAP9 RABEP1 ARHGAP29 BOD1L1 YWHAQ KIF13A CDC23 | 4.14e-06 | 509 | 145 | 15 | int:PFN1 |
| Interaction | KRT19 interactions | KRT7 KRT15 KRT83 ESR1 TEX9 HEXIM1 CEP350 AKAP9 NDC80 YWHAQ EXOC4 | 6.39e-06 | 282 | 145 | 11 | int:KRT19 |
| Interaction | YWHAG interactions | ESR1 KIF1B MCM2 PPEF2 SHTN1 TTK YWHAZ ST13 DENND4C HEXIM1 CEP350 HOXC10 AKAP9 RABEP1 ANKRD11 ARHGAP29 HELZ BOD1L1 YWHAQ LRBA BRD1 CTPS1 KIF13A EXOC4 | 9.39e-06 | 1248 | 145 | 24 | int:YWHAG |
| Interaction | NPAS1 interactions | 1.15e-05 | 245 | 145 | 10 | int:NPAS1 | |
| Interaction | KCNA3 interactions | EPPK1 CCDC73 KIF1B PSMD2 FYCO1 SHTN1 ITGB1 TTK DENND4C RABL6 CCT5 VANGL1 ARHGAP29 TMPO BOD1L1 EIF2AK4 LRBA CTPS1 EXOC4 | 1.61e-05 | 871 | 145 | 19 | int:KCNA3 |
| Interaction | AP2B1 interactions | ESR1 MCM2 PSMD2 YWHAZ HEXIM1 CEP350 AP1AR AKAP9 TMPO HEATR5B KIF13A CDC23 | 1.68e-05 | 373 | 145 | 12 | int:AP2B1 |
| Interaction | RGS12 interactions | 1.74e-05 | 45 | 145 | 5 | int:RGS12 | |
| Interaction | LAMTOR1 interactions | ESR1 NBEA SPG11 FYCO1 RABGAP1 ITGB1 TTK ST13 DENND4C RABL6 VANGL1 RABEP1 KIRREL1 LRBA TUBD1 FAM219A EXOC4 | 1.78e-05 | 722 | 145 | 17 | int:LAMTOR1 |
| Interaction | SLFN11 interactions | CCPG1 CENPF YWHAZ SETD2 CCT5 LTN1 TMPO HELZ YWHAQ BRD1 TUBD1 SRSF9 | 1.82e-05 | 376 | 145 | 12 | int:SLFN11 |
| Interaction | FBXO42 interactions | 1.86e-05 | 259 | 145 | 10 | int:FBXO42 | |
| Interaction | STX6 interactions | ESR1 NBEA RABGAP1 ITGB1 DENND4C RABL6 AP1AR STX4 VANGL1 RABEP1 LRBA KIF13A EXOC4 | 2.20e-05 | 448 | 145 | 13 | int:STX6 |
| Interaction | HDAC4 interactions | CACNA1A ESR1 ADGRB3 PSMD2 YWHAZ DENND4C ZFX KIF3A RABL6 NCOR2 THBS1 CCT5 ANKRD11 PLCB3 YWHAQ SPATS2 MCF2L | 2.61e-05 | 744 | 145 | 17 | int:HDAC4 |
| Interaction | ITPRID2 interactions | 2.61e-05 | 120 | 145 | 7 | int:ITPRID2 | |
| Interaction | RAB11A interactions | ESR1 NBEA RABGAP1 ITGB1 DENND4C HEXIM1 RABL6 STX4 VANGL1 RABEP1 TMPO KIRREL1 PLCG1 LRBA HEATR5B KIF13A FHIP1A EXOC4 | 2.96e-05 | 830 | 145 | 18 | int:RAB11A |
| Interaction | CAMSAP2 interactions | 3.11e-05 | 169 | 145 | 8 | int:CAMSAP2 | |
| Interaction | RNH1 interactions | 3.14e-05 | 220 | 145 | 9 | int:RNH1 | |
| Interaction | HSP90AA1 interactions | ESR1 MCM2 SPG11 RABGAP1 HIF3A LRRK1 ITGB1 TTK YWHAZ ST13 HEXIM1 GSTP1 THBS1 ARNT GLDC RPS6KA6 TMPO BOD1L1 YWHAQ SPATS2 NIPBL NEK11 PLCE1 | 3.49e-05 | 1263 | 145 | 23 | int:HSP90AA1 |
| Interaction | FBXO22 interactions | CENPF ESR1 NBEA SPG11 RABL6 NCOR2 CCT5 ANKRD11 FGB TMPO EIF2AK4 LRBA CTPS1 CDC23 | 3.64e-05 | 540 | 145 | 14 | int:FBXO22 |
| Interaction | RPTOR interactions | ESR1 PSMD2 YWHAZ DENND4C HEXIM1 GSTP1 CCT5 HELZ YWHAQ BRD1 MED23 | 3.73e-05 | 341 | 145 | 11 | int:RPTOR |
| Interaction | RPGRIP1L interactions | 3.74e-05 | 225 | 145 | 9 | int:RPGRIP1L | |
| Interaction | GPR17 interactions | 3.96e-05 | 283 | 145 | 10 | int:GPR17 | |
| Interaction | KIF5C interactions | 4.17e-05 | 88 | 145 | 6 | int:KIF5C | |
| Interaction | WWC2 interactions | 4.60e-05 | 28 | 145 | 4 | int:WWC2 | |
| Interaction | CEP63 interactions | 4.69e-05 | 179 | 145 | 8 | int:CEP63 | |
| Interaction | KRT6B interactions | 4.81e-05 | 132 | 145 | 7 | int:KRT6B | |
| Interaction | UACA interactions | 5.81e-05 | 136 | 145 | 7 | int:UACA | |
| Interaction | RNF43 interactions | PSMD2 TTK RABL6 VANGL1 FZD5 HELZ KIRREL1 YWHAQ LRBA SRSF9 PDZD4 EXOC4 | 6.26e-05 | 427 | 145 | 12 | int:RNF43 |
| Interaction | KRT72 interactions | 6.59e-05 | 59 | 145 | 5 | int:KRT72 | |
| Interaction | CDK5RAP2 interactions | 7.14e-05 | 190 | 145 | 8 | int:CDK5RAP2 | |
| Interaction | KIF5A interactions | 7.64e-05 | 98 | 145 | 6 | int:KIF5A | |
| Interaction | DUXAP9 interactions | 7.65e-05 | 12 | 145 | 3 | int:DUXAP9 | |
| Interaction | RAC1 interactions | DOCK2 DOCK3 RASGRF1 ESR1 ITGB1 YWHAZ DENND4C GSTP1 ARNT STX4 CXCR4 VANGL1 KCNJ12 TLR2 TMPO KIRREL1 PLCB3 LRBA MCF2L CDC23 | 7.67e-05 | 1063 | 145 | 20 | int:RAC1 |
| Interaction | FHIP1A interactions | 8.94e-05 | 33 | 145 | 4 | int:FHIP1A | |
| Interaction | SNW1 interactions | DOCK2 EPPK1 ESR1 PSMD2 RABGAP1 INTS3 TTK NCOR2 NDC80 CCT5 NUP37 RABEP1 TMPO NIPBL CDC23 EXOC4 | 9.76e-05 | 747 | 145 | 16 | int:SNW1 |
| Interaction | KLC1 interactions | 9.81e-05 | 255 | 145 | 9 | int:KLC1 | |
| Interaction | HSPH1 interactions | ESR1 MCM2 PSMD2 RABGAP1 ITGB1 TTK HEXIM1 GLDC DYNLL2 TMPO YWHAQ CTPS1 | 9.87e-05 | 448 | 145 | 12 | int:HSPH1 |
| Interaction | CSNK1A1 interactions | TANK ESR1 KIF1B ITGB1 YWHAZ DENND4C MALT1 DYNLL2 TMPO YWHAQ PLCE1 | 1.01e-04 | 381 | 145 | 11 | int:CSNK1A1 |
| Interaction | KCNQ5 interactions | 1.01e-04 | 34 | 145 | 4 | int:KCNQ5 | |
| Interaction | RAB9A interactions | TANK KIF1B NBEA SPG11 FYCO1 RABGAP1 ITGB1 DENND4C RABL6 AP1AR VANGL1 RABEP1 TMPO LRBA | 1.03e-04 | 595 | 145 | 14 | int:RAB9A |
| Interaction | MYH9 interactions | SAMD9 ESR1 MCM2 PSMD2 ITGB1 YWHAZ CD163 HEXIM1 THBS1 ARNT GLDC CXCR4 LTN1 TMPO PLCG1 YWHAQ | 1.09e-04 | 754 | 145 | 16 | int:MYH9 |
| Interaction | SMTNL2 interactions | 1.13e-04 | 35 | 145 | 4 | int:SMTNL2 | |
| Interaction | PFKFB3 interactions | 1.21e-04 | 67 | 145 | 5 | int:PFKFB3 | |
| Interaction | YWHAH interactions | EVC2 EPPK1 ZCCHC8 ESR1 KIF1B MCM2 PSMD2 SHTN1 TTK YWHAZ DENND4C CEP350 AKAP9 RABEP1 ANKRD11 BOD1L1 YWHAQ LRBA BRD1 EXOC4 | 1.25e-04 | 1102 | 145 | 20 | int:YWHAH |
| Interaction | PFKFB4 interactions | 1.57e-04 | 38 | 145 | 4 | int:PFKFB4 | |
| Interaction | STRN3 interactions | 1.67e-04 | 161 | 145 | 7 | int:STRN3 | |
| Interaction | CCDC71 interactions | 1.71e-04 | 72 | 145 | 5 | int:CCDC71 | |
| Interaction | TMCC3 interactions | 1.74e-04 | 39 | 145 | 4 | int:TMCC3 | |
| Interaction | KMT5B interactions | 1.74e-04 | 39 | 145 | 4 | int:KMT5B | |
| Interaction | MTCL2 interactions | 1.76e-04 | 114 | 145 | 6 | int:MTCL2 | |
| Interaction | TERF2IP interactions | ZNF609 ZCCHC8 ESR1 ZNF507 MCM2 COTL1 KANSL3 NCOR2 SETD2 ARNT ANKRD11 BOD1L1 NIPBL | 1.82e-04 | 552 | 145 | 13 | int:TERF2IP |
| Interaction | KANK1 interactions | 1.92e-04 | 40 | 145 | 4 | int:KANK1 | |
| Interaction | OFD1 interactions | TANK KRT83 PSMD2 DENND4C CEP350 NDC80 RABEP1 DYNLL2 CTPS1 EXOC4 | 2.13e-04 | 347 | 145 | 10 | int:OFD1 |
| Interaction | KIF5B interactions | NEK7 PSMD2 FYCO1 RABGAP1 YWHAZ ST13 HEXIM1 CCT5 YWHAQ FHIP1A | 2.18e-04 | 348 | 145 | 10 | int:KIF5B |
| Interaction | FASN interactions | ZNF609 NEK7 MCM2 PSMD2 SPG11 SHTN1 ITGB1 TTK HEXIM1 ZFX KIF3A ARNT GLDC TMPO HELZ SESN2 PLCG1 YWHAQ NIPBL | 2.25e-04 | 1062 | 145 | 19 | int:FASN |
| Interaction | KRT18 interactions | KRT7 PDE4B EPPK1 KRT15 ESR1 MCM2 YWHAZ HEXIM1 CEP350 YWHAQ CFAP46 | 2.30e-04 | 419 | 145 | 11 | int:KRT18 |
| Interaction | WDR64 interactions | 2.30e-04 | 17 | 145 | 3 | int:WDR64 | |
| Interaction | CCDC6 interactions | 2.32e-04 | 286 | 145 | 9 | int:CCDC6 | |
| Interaction | GRB2 interactions | KRT7 EPPK1 KRT15 KRT83 ESR1 PCDHB5 MCM2 LRRK1 YWHAZ KIF3A CCT5 HELZ KIRREL1 PLCG1 YWHAQ IL3RA | 2.32e-04 | 806 | 145 | 16 | int:GRB2 |
| Interaction | JCAD interactions | 2.33e-04 | 42 | 145 | 4 | int:JCAD | |
| Interaction | GGA1 interactions | 2.44e-04 | 121 | 145 | 6 | int:GGA1 | |
| Interaction | RCOR1 interactions | CENPF ZCCHC8 RABGAP1 SHTN1 DENND4C NCOR2 RABEP1 DYNLL2 LRBA MED23 CDC23 EXOC4 | 2.44e-04 | 494 | 145 | 12 | int:RCOR1 |
| Interaction | SAMD4B interactions | 2.55e-04 | 122 | 145 | 6 | int:SAMD4B | |
| Interaction | HSP90B1 interactions | ESR1 NEK7 MCM2 PSMD2 RABGAP1 SRBD1 SHTN1 INTS3 HEXIM1 GLDC DNAH17 TLR2 MCF2L SRSF9 | 2.56e-04 | 650 | 145 | 14 | int:HSP90B1 |
| Interaction | SQSTM1 interactions | CCPG1 JADE3 ESR1 PSMD2 LRRK1 TTK YWHAZ CEP350 GSTP1 MALT1 CCT5 NUP37 DYNLL2 TMPO HELZ SESN2 BRD1 CTPS1 HEATR5B NIPBL EXOC4 | 2.62e-04 | 1257 | 145 | 21 | int:SQSTM1 |
| Interaction | CCDC8 interactions | EPPK1 MCM2 PSMD2 ITGB1 YWHAZ CEP350 STX4 VANGL1 TMPO YWHAQ HEATR5B SRSF9 NIPBL CDC23 | 2.81e-04 | 656 | 145 | 14 | int:CCDC8 |
| Interaction | ABLIM1 interactions | 2.99e-04 | 177 | 145 | 7 | int:ABLIM1 | |
| Interaction | RBM7 interactions | 3.03e-04 | 126 | 145 | 6 | int:RBM7 | |
| Interaction | GJA1 interactions | PSMD2 NBEA RABGAP1 ITGB1 YWHAZ DENND4C GSTP1 STX4 VANGL1 KIRREL1 YWHAQ LRBA EXOC4 | 3.08e-04 | 583 | 145 | 13 | int:GJA1 |
| Interaction | FARSA interactions | 3.09e-04 | 178 | 145 | 7 | int:FARSA | |
| Interaction | PARD3 interactions | 3.14e-04 | 298 | 145 | 9 | int:PARD3 | |
| Interaction | SDC4 interactions | 3.15e-04 | 82 | 145 | 5 | int:SDC4 | |
| Interaction | DCLK1 interactions | 3.17e-04 | 127 | 145 | 6 | int:DCLK1 | |
| Interaction | AP1S3 interactions | 3.25e-04 | 19 | 145 | 3 | int:AP1S3 | |
| Interaction | ZBTB7B interactions | 3.25e-04 | 366 | 145 | 10 | int:ZBTB7B | |
| Interaction | CEP170B interactions | 3.33e-04 | 83 | 145 | 5 | int:CEP170B | |
| Interaction | NEK1 interactions | 3.52e-04 | 84 | 145 | 5 | int:NEK1 | |
| Interaction | PCNT interactions | 3.63e-04 | 241 | 145 | 8 | int:PCNT | |
| Interaction | DLG3 interactions | 3.74e-04 | 131 | 145 | 6 | int:DLG3 | |
| Interaction | CDK18 interactions | 3.74e-04 | 131 | 145 | 6 | int:CDK18 | |
| Interaction | ACKR3 interactions | 3.80e-04 | 20 | 145 | 3 | int:ACKR3 | |
| Interaction | NTRK3 interactions | CCPG1 RASGRF1 NBEA DENND4C RABL6 CXCR4 VANGL1 LTN1 PLCG1 LRBA | 3.85e-04 | 374 | 145 | 10 | int:NTRK3 |
| Interaction | TMPO interactions | ESR1 NEK7 PSMD2 FYCO1 ITGB1 ARNT STX4 CCT5 VANGL1 FGB TMPO EIF2AK4 YWHAQ BRD1 CTPS1 | 4.00e-04 | 762 | 145 | 15 | int:TMPO |
| Interaction | SPATA13 interactions | 4.41e-04 | 21 | 145 | 3 | int:SPATA13 | |
| Interaction | MYH14 interactions | 4.44e-04 | 189 | 145 | 7 | int:MYH14 | |
| Interaction | CEP95 interactions | 4.58e-04 | 50 | 145 | 4 | int:CEP95 | |
| Interaction | NHSL1 interactions | 4.58e-04 | 50 | 145 | 4 | int:NHSL1 | |
| Interaction | SASH1 interactions | 4.58e-04 | 50 | 145 | 4 | int:SASH1 | |
| Interaction | TNFAIP3 interactions | 4.73e-04 | 191 | 145 | 7 | int:TNFAIP3 | |
| Interaction | KCNJ5 interactions | 5.08e-04 | 22 | 145 | 3 | int:KCNJ5 | |
| Interaction | HCFC2 interactions | 5.35e-04 | 92 | 145 | 5 | int:HCFC2 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.24e-04 | 19 | 94 | 3 | 832 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 5.52e-04 | 7 | 94 | 2 | 1053 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 9.40e-04 | 9 | 94 | 2 | 1230 | |
| GeneFamily | Phospholipases | 1.35e-03 | 42 | 94 | 3 | 467 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.76e-03 | 46 | 94 | 3 | 622 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.05e-03 | 115 | 94 | 4 | 769 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 3.06e-03 | 16 | 94 | 2 | 276 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | KRT7 CCPG1 PDE4B KIF1B SLFN5 ITGB1 ZFX ZFY MALT1 THBS1 ARNT ART3 CXCR4 VANGL1 ARHGAP29 KIRREL1 LRBA MED23 HEATR5B KLK2 PLCE1 | 2.69e-08 | 888 | 147 | 21 | MM1018 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | KRT7 CCPG1 PDE4B KIF1B SLFN5 ITGB1 ZFX MALT1 THBS1 ARNT ART3 CXCR4 VANGL1 ARHGAP29 KIRREL1 LRBA MED23 HEATR5B PLCE1 | 3.34e-07 | 854 | 147 | 19 | M1533 |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | CACNA1A CAND2 KRT15 CENPF KRT83 MCM2 TTK COTL1 YWHAZ GSTP1 ARNT ART3 NDC80 GLDC DNAH17 KIRREL1 | 1.04e-06 | 662 | 147 | 16 | M8124 |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.65e-06 | 195 | 147 | 9 | M9808 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.95e-06 | 199 | 147 | 9 | M5893 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 ZNF609 PDE4B SAMD9 TANK WWC3 NEK7 SPG11 SLFN5 COTL1 YWHAZ CEP350 MALT1 SETD2 AKAP9 CXCR4 ANKRD11 HELZ BOD1L1 PLCG1 YWHAQ LRBA AP4B1 NIPBL | 2.95e-06 | 1492 | 147 | 24 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TANK CENPF NEK7 SPG11 RABGAP1 TTK CEP350 MALT1 NCOR2 SETD2 AKAP9 NDC80 LTN1 ARHGAP29 HELZ NIPBL PLCE1 | 6.61e-06 | 856 | 147 | 17 | M4500 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 1.50e-05 | 195 | 147 | 8 | M7310 | |
| Coexpression | FARMER_BREAST_CANCER_BASAL_VS_LULMINAL | 1.76e-05 | 329 | 147 | 10 | M5652 | |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 5.46e-05 | 172 | 147 | 7 | M8234 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 5.84e-05 | 236 | 147 | 8 | M130 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | CCPG1 TANK CENPF KIF1B MCM2 ITGB1 TTK YWHAZ AP1AR TMPO KIRREL1 SESN2 CTPS1 | 7.24e-05 | 644 | 147 | 13 | M10501 |
| Coexpression | FUJII_YBX1_TARGETS_DN | 1.16e-04 | 194 | 147 | 7 | M14340 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | DOCK3 PRAMEF10 CENPF KRT83 CCDC80 HIF3A LRRK1 CCDC141 ZFY CRYGA MALT1 PPP2R2C KIRREL1 ST18 FHIP1A | 1.22e-04 | 873 | 147 | 15 | M16009 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | DOCK3 CENPF MCM2 NBEA TEX9 TTK PPP2R2C NDC80 TMPO YWHAQ CTPS1 ST18 PDZD4 | 1.24e-04 | 680 | 147 | 13 | MM456 |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 1.36e-04 | 199 | 147 | 7 | M8314 | |
| Coexpression | GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN | 1.40e-04 | 200 | 147 | 7 | M8694 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_DN | 1.40e-04 | 200 | 147 | 7 | M3802 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.40e-04 | 200 | 147 | 7 | M8959 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN | 1.40e-04 | 200 | 147 | 7 | M4030 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CCPG1 CAND2 KRT15 CENPF ZNF507 TEX9 AKAP9 RPS6KA6 TMPO BOD1L1 EIF2AK4 YWHAQ BRD1 MED23 HEATR5B NIPBL | 6.54e-06 | 629 | 145 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.33e-08 | 199 | 148 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.43e-08 | 200 | 148 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-07 | 175 | 148 | 8 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.40e-07 | 198 | 148 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-06 | 184 | 148 | 7 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 195 | 148 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 195 | 148 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-06 | 196 | 148 | 7 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.55e-06 | 198 | 148 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-06 | 198 | 148 | 7 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-06 | 198 | 148 | 7 | ddec07c7bc26d35f155537d907b46e2cb5b55b5f | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD14|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-06 | 200 | 148 | 7 | 54221271becd02a4ffa826e06c8e76fcd2651d50 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.86e-06 | 200 | 148 | 7 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 4.86e-06 | 200 | 148 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.86e-06 | 200 | 148 | 7 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.86e-06 | 200 | 148 | 7 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.86e-06 | 200 | 148 | 7 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.86e-06 | 200 | 148 | 7 | 8fd88dfc6e08e0186fc0f061526ad98a3b00bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-05 | 161 | 148 | 6 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 166 | 148 | 6 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 166 | 148 | 6 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 168 | 148 | 6 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 170 | 148 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 171 | 148 | 6 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 6b01448443cf8392ed8248ff452b80c31240b85d | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 0c0ae2da3cba6022403434567800f16e61a34a2b | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | d80c207f3489be2da2f40f47a7835cb73c949c3e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 172 | 148 | 6 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 175 | 148 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.83e-05 | 177 | 148 | 6 | fd739ae4a574b72dc26a2a9ff4ef988454298ead | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 184 | 148 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.73e-05 | 186 | 148 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 187 | 148 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-05 | 189 | 148 | 6 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 190 | 148 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 190 | 148 | 6 | 7c402aa47f1bd7decacc366c1ed1a37e39b95c73 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.20e-05 | 190 | 148 | 6 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 190 | 148 | 6 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.20e-05 | 190 | 148 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 4.32e-05 | 191 | 148 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-05 | 192 | 148 | 6 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.45e-05 | 192 | 148 | 6 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.45e-05 | 192 | 148 | 6 | 3856c4d611224cd6c2558631147cd5333bc0ccb7 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 4.58e-05 | 193 | 148 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 193 | 148 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.58e-05 | 193 | 148 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 193 | 148 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 193 | 148 | 6 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | (2)_MNPs|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.72e-05 | 194 | 148 | 6 | 9cd64e325ec233da82c463b09262efe93d2a92ee | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-05 | 194 | 148 | 6 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-05 | 194 | 148 | 6 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-05 | 195 | 148 | 6 | 0b0615553b9a1b60d666d074ce4260919e2d5642 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | 367C-Myeloid-Monocyte-CD14+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-05 | 195 | 148 | 6 | 4f9e26e033353fc9a8bdbd10358ee68ab2291880 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 196 | 148 | 6 | 31b91cba24f20a336d340c747eaafde7bbe2a428 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.99e-05 | 196 | 148 | 6 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.99e-05 | 196 | 148 | 6 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 196 | 148 | 6 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 367C-Myeloid-Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-05 | 196 | 148 | 6 | 202066aeb837659fcc2e127fb52d7189e2e3520d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 197 | 148 | 6 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 197 | 148 | 6 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | distal-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-05 | 197 | 148 | 6 | 6fcca7c071e35786b715adeb18be317d34315d7e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 121 | 148 | 5 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.28e-05 | 198 | 148 | 6 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.28e-05 | 198 | 148 | 6 | 100091c91fde604daf110f20b44505f240f93ae8 | |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | 5.28e-05 | 198 | 148 | 6 | 19c5d6b65de490118574b1f86b45c58b3a51df7f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 198 | 148 | 6 | 55ea8c9d2154ded74c7b851735b24c95bae01de4 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.28e-05 | 198 | 148 | 6 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.28e-05 | 198 | 148 | 6 | 73e9ada6998c09ae3a3a66e920b28694b7f9cf6b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 198 | 148 | 6 | fc7d8b8e710eedd6cfc1e5393f0c23feac283807 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.28e-05 | 198 | 148 | 6 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | (3)_Monocyte|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.28e-05 | 198 | 148 | 6 | dff753c3d6919ea9f504bdc9859ed542a5490a9d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.28e-05 | 198 | 148 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | MS-cycling|MS / Condition, Cell_class and T cell subcluster | 5.28e-05 | 198 | 148 | 6 | 0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 199 | 148 | 6 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.43e-05 | 199 | 148 | 6 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic-Classical_monocytes|blood / Manually curated celltypes from each tissue | 5.43e-05 | 199 | 148 | 6 | cd4528ae4a4d8ed1da20b268c556ab9b3f03c374 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.43e-05 | 199 | 148 | 6 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.43e-05 | 199 | 148 | 6 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.43e-05 | 199 | 148 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.58e-05 | 200 | 148 | 6 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| Computational | Neighborhood of RRM1 | 2.25e-04 | 88 | 106 | 6 | GNF2_RRM1 | |
| Computational | Neighborhood of RFC4 | 3.01e-04 | 60 | 106 | 5 | GNF2_RFC4 | |
| Computational | Neighborhood of CDC2 | 3.51e-04 | 62 | 106 | 5 | GNF2_CDC2 | |
| Computational | Neighborhood of CENPF | 3.51e-04 | 62 | 106 | 5 | GNF2_CENPF | |
| Computational | Neighborhood of CCNA2 | 5.40e-04 | 68 | 106 | 5 | GNF2_CCNA2 | |
| Computational | Neighborhood of PCNA | 5.40e-04 | 68 | 106 | 5 | GNF2_PCNA | |
| Computational | Neighborhood of TTK | 5.63e-04 | 39 | 106 | 4 | GNF2_TTK | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.57e-07 | 194 | 144 | 10 | 4727_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | SAMD9 KRT15 CENPF RABGAP1 ITGB1 THBS1 DNAH17 PLCB3 MCF2L SPINK5 | 5.26e-07 | 197 | 144 | 10 | 6018_DN |
| Drug | Polychlorinated Biphenyls | CENPF ESR1 MCM2 SLFN5 LRRK1 KIF3A MALT1 THBS1 PPP2R2C ARNT CLCN3 NDC80 FZD5 TMPO CTPS1 IL1A | 2.69e-06 | 633 | 144 | 16 | ctd:D011078 |
| Drug | Diclofenac | TANK ITGB1 GSTP1 PPP2R2C ARNT GLDC CXCR4 FZD5 TLR2 FGB EIF2AK4 PLCG1 YWHAQ CTPS1 IL1A | 3.47e-06 | 570 | 144 | 15 | ctd:D004008 |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A | 3.66e-06 | 191 | 144 | 9 | 5085_DN | |
| Drug | tranilast | 4.89e-06 | 6 | 144 | 3 | ctd:C012293 | |
| Drug | Air Pollutants | CCPG1 SAMD9 CENPF CCDC80 NBEA SPG11 SLFN5 COTL1 S100A3 GSTP1 AKAP9 NDC80 FGB YWHAQ LRBA CTPS1 IL1A MMUT NEK11 | 5.45e-06 | 917 | 144 | 19 | ctd:D000393 |
| Drug | histamine | PDE4B GSTP1 ART3 TLR2 DYNLL2 PLCB3 EIF2AK4 PLCG1 LRBA IL1A TUBD1 KLK2 IL3RA PLCE1 | 1.33e-05 | 560 | 144 | 14 | CID000000774 |
| Drug | wartmannin | DOCK2 ESR1 ITGB1 SETD2 ARNT STX4 CLCN3 ART3 NDC80 CXCR4 TLR2 DYNLL2 RPS6KA6 FGB PLCG1 LRBA EXOC4 | 1.53e-05 | 811 | 144 | 17 | CID000005691 |
| Drug | pyrachlostrobin | CENPF NEK7 MCM2 CCDC80 SLFN5 LRRK1 ITGB1 DENND4C THBS1 GLDC VANGL1 FZD5 TLR2 KIRREL1 SESN2 PLCB3 PLCE1 | 1.53e-05 | 811 | 144 | 17 | ctd:C513428 |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 2.05e-05 | 181 | 144 | 8 | 1791_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 191 | 144 | 8 | 2857_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 3.13e-05 | 192 | 144 | 8 | 2865_DN | |
| Drug | AGN 1135 | 3.26e-05 | 141 | 144 | 7 | CID000122316 | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 5783_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 3246_UP | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; PC3; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 5888_UP | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 5775_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 6641_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 3.89e-05 | 198 | 144 | 8 | 842_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 6176_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 6818_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 6687_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; HL60; HG-U133A | 3.89e-05 | 198 | 144 | 8 | 1551_UP | |
| Drug | cobamamide | 3.97e-05 | 2 | 144 | 2 | ctd:C000913 | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 4.18e-05 | 200 | 144 | 8 | 1474_UP | |
| Drug | phenethyl isothiocyanate | CCPG1 CENPF MCM2 SLFN5 YWHAZ GSTP1 KCNJ12 TMPO BOD1L1 YWHAQ IL1A | 5.08e-05 | 401 | 144 | 11 | ctd:C058305 |
| Drug | GF109203X | CACNA1A THBS1 CLCN3 ART3 RPS6KA6 TMPO PLCB3 PLCG1 LRBA PLCE1 | 6.49e-05 | 341 | 144 | 10 | CID000002396 |
| Drug | Gdrgdsp | 6.84e-05 | 109 | 144 | 6 | CID000115346 | |
| Drug | phorbol acetate myristate | CACNA1A RAG2 KRT7 KRT15 KRT83 ESR1 PSMD2 ITGB1 CD163 GSTP1 MALT1 SETD2 STX4 ART3 NDC80 DYNLL2 RPS6KA6 PLCB3 PLCG1 LRBA IL1A PLCE1 | 6.88e-05 | 1399 | 144 | 22 | CID000004792 |
| Drug | ST271 | 6.90e-05 | 35 | 144 | 4 | CID006439072 | |
| Drug | cetyltrimethylammonium bromide | 7.14e-05 | 68 | 144 | 5 | CID000002681 | |
| Drug | AC1MU1S9 | RAG2 RASGRF1 ITGB1 SETD2 STX4 ART3 CXCR4 DYNLL2 PLCB3 PLCG1 LRBA IL1A PLCE1 | 7.25e-05 | 572 | 144 | 13 | CID000003733 |
| Drug | genistein | CACNA1A ESR1 ITGB1 SETD2 THBS1 PPP2R2C CLCN3 ART3 NDC80 DYNLL2 RPS6KA6 TMPO PLCB3 PLCG1 LRBA IL1A KLK2 IL3RA PLCE1 | 8.19e-05 | 1117 | 144 | 19 | CID005280961 |
| Drug | Simvastatin | PDE4B TANK KRT15 RASGRF1 ITGB1 GSTP1 THBS1 CLCN3 CXCR4 TLR2 ARHGAP29 SESN2 IL1A | 8.48e-05 | 581 | 144 | 13 | ctd:D019821 |
| Drug | sulprostone | 8.79e-05 | 71 | 144 | 5 | CID005312153 | |
| Drug | Clorgyline | 9.89e-05 | 168 | 144 | 7 | ctd:D003010 | |
| Disease | osteoporosis (is_implicated_in) | 1.46e-05 | 31 | 142 | 4 | DOID:11476 (is_implicated_in) | |
| Disease | Shared Paranoid Disorder | 6.88e-05 | 3 | 142 | 2 | C0036939 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.08e-04 | 51 | 142 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Malignant neoplasm of breast | TANK CENPF ESR1 COTL1 GSTP1 SETD2 THBS1 AKAP9 CCT5 CXCR4 ARHGAP29 BOD1L1 LRBA NIPBL PDZD4 | 2.17e-04 | 1074 | 142 | 15 | C0006142 |
| Disease | age at first birth measurement | 2.94e-04 | 120 | 142 | 5 | EFO_0009101 | |
| Disease | total blood protein measurement | 3.39e-04 | 449 | 142 | 9 | EFO_0004536 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.49e-04 | 69 | 142 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Eosinophilia, Tropical | 4.75e-04 | 7 | 142 | 2 | C0014458 | |
| Disease | osteopetrosis (implicated_via_orthology) | 4.75e-04 | 7 | 142 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 5.25e-04 | 477 | 142 | 9 | C0005586 | |
| Disease | Eosinophilia | 6.32e-04 | 8 | 142 | 2 | C0014457 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 6.32e-04 | 8 | 142 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 6.35e-04 | 142 | 142 | 5 | DOID:10534 (is_marker_for) | |
| Disease | birth weight | 7.25e-04 | 399 | 142 | 8 | EFO_0004344 | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0008240 | |
| Disease | migraine (is_implicated_in) | 8.10e-04 | 9 | 142 | 2 | DOID:6364 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 8.14e-04 | 150 | 142 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | lifestyle measurement | 9.95e-04 | 235 | 142 | 6 | EFO_0010724 | |
| Disease | colorectal cancer (is_marker_for) | 9.98e-04 | 157 | 142 | 5 | DOID:9256 (is_marker_for) | |
| Disease | cutaneous leishmaniasis (is_marker_for) | 1.01e-03 | 10 | 142 | 2 | DOID:9111 (is_marker_for) | |
| Disease | cholesteatoma (is_marker_for) | 1.01e-03 | 10 | 142 | 2 | DOID:869 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 1.03e-03 | 525 | 142 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.03e-03 | 525 | 142 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.06e-03 | 527 | 142 | 9 | C1458155 | |
| Disease | Breast Carcinoma | 1.22e-03 | 538 | 142 | 9 | C0678222 | |
| Disease | Prostatic Intraepithelial Neoplasias | 1.23e-03 | 11 | 142 | 2 | C0282612 | |
| Disease | Internal Carotid Artery Diseases | 1.23e-03 | 11 | 142 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 1.23e-03 | 11 | 142 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 1.23e-03 | 11 | 142 | 2 | C0577631 | |
| Disease | External Carotid Artery Diseases | 1.23e-03 | 11 | 142 | 2 | C0600178 | |
| Disease | Carotid Artery Diseases | 1.23e-03 | 11 | 142 | 2 | C0007273 | |
| Disease | Abruptio Placentae | 1.47e-03 | 12 | 142 | 2 | EFO_1001754 | |
| Disease | cardiac troponin I change measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0600077 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.81e-03 | 50 | 142 | 3 | C1449563 | |
| Disease | Metabolic Bone Disorder | 2.01e-03 | 14 | 142 | 2 | C0005944 | |
| Disease | C-X-C motif chemokine 11 measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0008057 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 2.14e-03 | 53 | 142 | 3 | EFO_0008464 | |
| Disease | eosinophil count | DOCK3 SH3TC2 PSMD2 KIF3A KANSL3 MALT1 NCOR2 SETD2 AKAP9 GLDC CXCR4 RABEP1 ANKRD11 SESN2 PLCB3 TUBD1 | 2.20e-03 | 1488 | 142 | 16 | EFO_0004842 |
| Disease | Osteopenia | 2.32e-03 | 15 | 142 | 2 | C0029453 | |
| Disease | thrombosis (is_implicated_in) | 2.32e-03 | 15 | 142 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | phenylalanine measurement | 2.38e-03 | 55 | 142 | 3 | EFO_0005001 | |
| Disease | non-high density lipoprotein cholesterol measurement | CACNA1A TDRD15 ST13 DENND4C CD163 STX4 RABEP1 FGB HELZ PLCE1 | 2.44e-03 | 713 | 142 | 10 | EFO_0005689 |
| Disease | prostate cancer (is_implicated_in) | 2.50e-03 | 117 | 142 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 2.51e-03 | 56 | 142 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | age at first sexual intercourse measurement | 2.62e-03 | 383 | 142 | 7 | EFO_0009749 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 2.64e-03 | 16 | 142 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 2.64e-03 | 16 | 142 | 2 | DOID:10964 (is_marker_for) | |
| Disease | response to phenylephrine | 2.98e-03 | 17 | 142 | 2 | EFO_0010152 | |
| Disease | Astrocytosis | 2.98e-03 | 17 | 142 | 2 | C3887640 | |
| Disease | Psychoses, Substance-Induced | 2.98e-03 | 17 | 142 | 2 | C0033941 | |
| Disease | Gliosis | 2.98e-03 | 17 | 142 | 2 | C0017639 | |
| Disease | factor XI measurement, Ischemic stroke | 2.98e-03 | 17 | 142 | 2 | EFO_0004694, HP_0002140 | |
| Disease | body fat distribution | 3.01e-03 | 202 | 142 | 5 | EFO_0004341 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.20e-03 | 61 | 142 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Arsenic Induced Polyneuropathy | 3.35e-03 | 62 | 142 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 3.35e-03 | 62 | 142 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 3.35e-03 | 62 | 142 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 3.35e-03 | 62 | 142 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 3.35e-03 | 62 | 142 | 3 | C0274862 | |
| Disease | eosinophil percentage of leukocytes | DOCK3 TCEA3 SH3TC2 PSMD2 HIF3A KIF3A KANSL3 SETD2 CXCR4 SESN2 | 3.36e-03 | 746 | 142 | 10 | EFO_0007991 |
| Disease | receptive language perception | 3.73e-03 | 19 | 142 | 2 | EFO_0005686 | |
| Disease | Alzheimer's disease (is_implicated_in) | 3.86e-03 | 132 | 142 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.92e-03 | 215 | 142 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | cannabis dependence | 4.18e-03 | 135 | 142 | 4 | EFO_0007191 | |
| Disease | aspartate aminotransferase measurement | ANKRD31 WWC3 FYCO1 RABGAP1 CD163 NCOR2 NUP37 ARHGAP29 LRBA MMUT PLCE1 | 4.42e-03 | 904 | 142 | 11 | EFO_0004736 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.49e-03 | 222 | 142 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Cardiomyopathies, Primary | 4.53e-03 | 69 | 142 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 4.53e-03 | 69 | 142 | 3 | C0036529 | |
| Disease | Psychoses, Drug | 4.55e-03 | 21 | 142 | 2 | C0033937 | |
| Disease | vitiligo (is_implicated_in) | 4.55e-03 | 21 | 142 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.64e-03 | 139 | 142 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | lymphocyte count | DOCK2 SH3TC2 EPPK1 KIF1B HIF3A SETD2 CXCR4 RABEP1 DNAH17 ANKRD11 HELZ KIRREL1 SESN2 TUBD1 PLCE1 | 4.72e-03 | 1464 | 142 | 15 | EFO_0004587 |
| Disease | Non-alcoholic Fatty Liver Disease | 4.72e-03 | 70 | 142 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 4.72e-03 | 70 | 142 | 3 | C3241937 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.75e-03 | 225 | 142 | 5 | EFO_0008317, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SDAYLADRDMECLSQ | 301 | A0A0G2JMD5 | |
| SKDMEDSVGLDCKRY | 96 | Q8TAA9 | |
| MEEYSLEKNERACID | 1521 | O00555 | |
| RCDDDQMSNDKERFA | 61 | P27540 | |
| SADIRDCDYSLANLM | 46 | Q9NYP8 | |
| VNSDCETYMSADDLR | 181 | Q9Y2T4 | |
| KLAEQAERYDDMATC | 11 | P27348 | |
| FDLIIDNCMKYNARD | 631 | O95696 | |
| VREYMENEKDKALCS | 1131 | Q99996 | |
| NDSRMLVALGECYEK | 431 | Q9UJX2 | |
| LQDVDDKYDRMKTCL | 2591 | Q6UB99 | |
| YDSMKEPCFREENAN | 21 | P61073 | |
| QMEYCEKSTLRDTID | 801 | Q9P2K8 | |
| VYLCTDDNLRGADMD | 1281 | O60242 | |
| YCIEEEKDMAVRDRG | 501 | Q9Y6B7 | |
| NLEEFENCVTEYMKA | 101 | Q8IYW2 | |
| DDYRGLMSELTDDCA | 96 | P11844 | |
| EDDFESCLRNMKSQY | 151 | Q63HQ0 | |
| RGRCDDQTAEKLMTY | 426 | Q9HA90 | |
| QRDEYLESFCKMATR | 641 | Q76M96 | |
| ALACKLDYDEDASAM | 206 | P50502 | |
| YMLKCAEDDTNEEQT | 346 | P55895 | |
| LYEKLDREVMCGATE | 86 | Q9Y5E4 | |
| AEKSCRTDLEMYVAV | 226 | Q15276 | |
| EMALDAEFLDVYKNC | 126 | Q3YEC7 | |
| MSDKDESCYDNAEAA | 521 | Q68E01 | |
| EVNSEDMDAYCRKEN | 506 | P05556 | |
| DMDAYCRKENSSEIC | 511 | P05556 | |
| DIDDCDTLAQTRMYD | 1126 | Q9UPP5 | |
| DMCKENRESLVVNYE | 221 | P49736 | |
| YSALRCCDNDMERKK | 686 | O94822 | |
| KMAKNCDTERNYIDR | 1056 | Q8N7Z5 | |
| YRSEENAKKLMELAC | 791 | Q9Y3P9 | |
| DVMADARALERACYE | 1491 | Q9Y618 | |
| DMFEDLKNCYSENEE | 6 | P01583 | |
| NDMCARAYSEKVTEF | 181 | P20151 | |
| DEKSQRYLADMFTTC | 61 | Q14500 | |
| SYICEAAFDEVKMAA | 626 | P42166 | |
| LDMCRKRNDYDDTIP | 461 | Q9UDY8 | |
| AQYEEMAKCSRAEAE | 266 | P08729 | |
| KSEDVQYFDMEDCVL | 1181 | Q38SD2 | |
| ECAEYREQMKNGRLS | 706 | Q9NQ38 | |
| IMDYQSRLKNAGEEC | 1011 | Q9BQS8 | |
| LFEKINDNCNEEMSY | 126 | O60333 | |
| CEVDEQESSEAYMRK | 111 | O14990 | |
| YLELEKCLSRMEDEN | 291 | O94992 | |
| KLESDVSAQMEYCRT | 211 | P02675 | |
| MESAKETRYCAVCND | 176 | P03372 | |
| KLGLMVCYRTDDEED | 141 | Q76G19 | |
| MADDNVKDYFECSLS | 11 | Q07343 | |
| QIFDLMDAKARADCI | 66 | Q8TDX7 | |
| DCDAREGESVAMNYK | 31 | Q8IW50 | |
| DTYLKCAMNAREENP | 1046 | Q9ULK4 | |
| LKMNSDTVDYDDACL | 1741 | Q6KC79 | |
| CRYSEMTLEDKNLDC | 296 | Q8NG66 | |
| EYDRKMVALTAECDL | 446 | Q86UK5 | |
| AECDLETRKKMENQY | 456 | Q86UK5 | |
| CAQYSADKREDEKMC | 1921 | P50851 | |
| EIKDGERCLDSVMCY | 421 | Q2TBA0 | |
| SELRCEMEAQNQEYK | 376 | P19012 | |
| YMDESASADSIRICD | 551 | Q9UK32 | |
| FSEDKRITLYECMAQ | 86 | A6NET4 | |
| MKQDASRNAAYTVDC | 1 | Q8NFH4 | |
| EREKSMCYKQAVSVD | 26 | Q9Y496 | |
| EQACESLKRQDYEMA | 11 | P42694 | |
| VDSAKQQAKMAEYCR | 416 | Q01970 | |
| LCMQRQDEYEKAKSS | 331 | Q52LW3 | |
| RRSESYSEDKCDMDS | 866 | Q8NFC6 | |
| RDAEVLCMDYNRSEA | 141 | Q13467 | |
| EGEDSAVLMERLCKY | 541 | B5ME19 | |
| SELAKSFQDMADRCL | 761 | Q96A65 | |
| HEDELNDMKDYLSQC | 251 | Q9ULG6 | |
| ENVMRKDELQYCALS | 771 | Q711Q0 | |
| DVMVYRLCAEKDSED | 641 | Q05DH4 | |
| NVTDIECVKDADYSM | 46 | P26951 | |
| TIQRMEDKDEGNYSC | 736 | Q8N6C5 | |
| REAAEVCEYAMSLAK | 1096 | Q9P2D3 | |
| SVEYCAMRDEINELK | 896 | Q6ZP82 | |
| EAISLCKELAEQYEM | 1296 | Q92608 | |
| LDYRDCMKGEETENK | 1201 | Q8IZD9 | |
| MATKIDKEACRAAYN | 1 | Q14019 | |
| LLSNEIMDKDRCYQD | 741 | P49454 | |
| KEDEYMVFDQECDLS | 1636 | Q9UFH2 | |
| KMEETQCYKRALDAQ | 476 | Q6ZN84 | |
| MENFCSDTEYREKEE | 431 | Q6ZRK6 | |
| NYDEDELCVKMQLAD | 3076 | Q5VT06 | |
| CIDLDTNMLYVSDEK | 486 | Q5VZ89 | |
| QISACNKDIYVDLDM | 106 | P03951 | |
| DMVNDGVEDLRCKYI | 91 | P09211 | |
| KEENVCCMYSAEKRA | 106 | Q9NYD6 | |
| MLKYSRNCEGAEDLQ | 781 | O15068 | |
| YDNQKARSVMNECER | 91 | Q9P2N6 | |
| RCDTIDTREEYEMKD | 586 | Q96J84 | |
| YREMNSCLNADDLDL | 1096 | Q86VB7 | |
| DDGLDVRKAAFECMY | 1081 | O75155 | |
| EAKYVDMCASAEVQR | 191 | D6RIA3 | |
| LAASVCRYDLDDMDI | 131 | Q92613 | |
| AVDCATQAMEKYNIE | 21 | Q96FJ2 | |
| MDCIVAEIKAQYDDI | 276 | P78385 | |
| DRFAQDSEMKKCSDY | 91 | O14830 | |
| DDMDSYQEEDLNCVR | 1081 | Q9H1H9 | |
| NFMEVTDRKCSELLY | 1221 | Q86VV8 | |
| DEKSQRYLADMFTTC | 61 | B7U540 | |
| MIVADSECRAELKDY | 1 | P58004 | |
| MREAGDVCYADVQKD | 131 | Q13242 | |
| EDEETLCEYAVAMKN | 66 | Q1RMZ1 | |
| NKFYDLCENDEMILR | 516 | B5MCY1 | |
| DSNKMRVCISKYVED | 1011 | B5MCY1 | |
| DAMAQHESSCEYRKV | 676 | Q9P212 | |
| MLEKDIDENAYAKVC | 216 | Q13200 | |
| YERLEAMIQNCADSS | 711 | Q5K651 | |
| SLDMKFTYCDDRIAE | 246 | Q9Y2N7 | |
| QCAQYAADRREEEKM | 2006 | Q8NFP9 | |
| MEDDRVKRYLEGTSC | 2211 | P58107 | |
| KEMADRYDRLLETCS | 286 | P17812 | |
| EKCNRVSMLAVEEYE | 201 | A0MZ66 | |
| KAYEAFRQACMDRDS | 11 | Q92844 | |
| EADKCPTLEQYAMRA | 436 | P48643 | |
| YCELQASKETDMELV | 906 | Q8TF17 | |
| CNSMQSEYREKNVER | 141 | Q12846 | |
| REAEMSRSDASLYCD | 616 | Q13972 | |
| CRETEAYFADLIMKN | 601 | Q8N5C6 | |
| AYDCSMAKKRTAEDQ | 31 | O60284 | |
| KLAEQAERYDDMAAC | 11 | P63104 | |
| LCDYRNDMNASKIVD | 471 | P51790 | |
| LMLDAAESYAKDSCV | 2271 | Q96JI7 | |
| MRENEAYQASCKERF | 36 | Q9UJT1 | |
| KQAFAELESCLMDRE | 271 | Q86XZ4 | |
| QEDRAQLYIDCEKME | 161 | P07996 | |
| ISEKRKEYMDACGEA | 251 | Q6NZY4 | |
| EACTDMKREYDQCFN | 6 | O43715 | |
| RDNDVAVTNCAMSYK | 1281 | Q92752 | |
| NDAFDSLERKCMEKE | 621 | O15014 | |
| DEEKIGTERACYRDM | 966 | P19174 | |
| SDAYLTDRDMECLSQ | 301 | O60809 | |
| CVEMLSAALKADDDY | 191 | O75764 | |
| SDRDCKTETSYLEME | 491 | Q9BYW2 | |
| EGMDDVYRADKCTVD | 436 | Q8TCN5 | |
| DDARDYFQMARANCK | 126 | P33981 | |
| QDDDKGNCEDYLMIS | 201 | P17010 | |
| YDESCSKEIQMAVLL | 191 | Q969U7 | |
| RECDYNKFMSVLDTN | 51 | P33764 | |
| LMVEEYLKNSACEDA | 371 | O60603 | |
| MKSCDDEDDYSLRGL | 76 | Q8N6V9 | |
| DVMDSQEALAFLKCR | 126 | Q08AF3 | |
| NMNERKCVEEAYSLL | 51 | Q9NXG2 | |
| EYQQLHKMCEDDSRS | 56 | Q9ULE0 | |
| QEDLLRDSMEEKYCG | 206 | Q9UL59 | |
| EQACEDMDILKSESY | 91 | P17097 | |
| QQDNDKASCEDYLMI | 196 | P08048 | |
| KASCEDYLMISLDDA | 201 | P08048 | |
| YSEDSLAMACDDIQR | 416 | Q5TIE3 | |
| EDKAELDRFCDAMIS | 911 | P23378 | |
| MADNAFDDEYLKCTD | 31 | Q13508 | |
| MECLTNDVYDAALKL | 431 | P22033 | |
| KVDREYEECMSEDLS | 606 | O14777 |